 Sangamo Therapeutics, Inc. NASDAQ:SGMO Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Louise Wilkie - Investor Relations Sandy Macrae - Chief Executive Officer Rob Schott - Head of Development Jason Fontenot - Chief Scientific Officer Prathyusha Duraibabu - Chief Financial Officer Bettina Cockroft - Chief Medical Officer Mark McClung - Chief Operating Officer Conference Call Participants Gregory Harrison - Bank of America Yanan Zhu - Wells Fargo Harshita Polishetty - Barclays Ritu Baral - Cowen and Company Lisa Walter - RBC Capital Maury Raycroft - Jefferies Jason Shieh - H.C. Wainwright Co. Andreas Argyrides - Wedbush Securities Operator Ladies and gentlemen, thank you for standing by, and welcome to Sangamo Second Quarter 2022 Earnings Conference Call. 